NCCM
GILD icon

Nine Chapters Capital Management’s Gilead Sciences GILD Stock Holding History

Nine Chapters Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,200
Closed -$1.09M – 264
2016
Q4 		$1.09M Buy
15,200
+9,900
+187% +$736K 1.84% 7
2016
Q3 		$419K Buy
+5,300
New +$431K 2.95% 4
2015
Q1 		– Sell
-5,300
Closed -$500K – 1029
2014
Q4 		$500K Buy
+5,300
New +$548K 0.04% 540
2014
Q2 		– Sell
-18,500
Closed -$1.31M – 1000
2014
Q1 		$1.31M Buy
+18,500
New +$1.45M 0.15% 190

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Nine Chapters Capital Management's GILD Position: Q1 2017 in Review

Nine Chapters Capital Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 15,200 shares — an estimated $1.09M sold.

Nine Chapters Capital Management first reported a position in GILD in Q1 2014 and held it in 4 quarters. The position peaked at $1.31M in Q1 2014. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Nine Chapters Capital Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Nine Chapters Capital Management sold 15,200 Gilead Sciences shares in Q1 2017, an estimated $1.09M.
  • Nine Chapters Capital Management first reported a position in Gilead Sciences in Q1 2014 and held it in 4 quarters.
  • Nine Chapters Capital Management's Gilead Sciences position peaked at $1.31M in Q1 2014.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Nine Chapters Capital Management's 13F filing for Q1 2017, filed 8 May 2017.